Literature DB >> 15627741

Effect of daily hemodialysis on monocytes apoptosis.

Emilio Andrikos1, Emanuela Buoncristiani, Vincenzo D'Intini, Valeria Bordoni, Monica Bonello, Nathan Levin, Umberto Buoncristiani, Michail Pappas, Claudio Ronco.   

Abstract

Uremia is associated with a state of immune dysfunction with increased susceptibility to infection and malignancy possibly related to dysregulation of immune system cell apoptosis. Peritoneal dialysis can restore plasma apoptosis activity on monocytes compared to intermittent hemodialysis. Whether the continuous modality or diverse clearance mechanisms involved are responsible is unknown. Apoptosis rates correlate with phagocytic function highlighting the benefit of efficient toxin clearance. The plasma of 16 patients on daily hemodialysis (D-HD) was incubated with U937 monocytes and compared to 18 hemodialysis (HD) patients, 5 chronic renal failure (CRF) subjects and 5 healthy volunteers (controls). Apoptosis was evaluated by immunofluorescence microscopy dyes (Hoechst 33342, propidium iodide) and annexin V cytoflowmetry at 96 h. Plasma-induced U937 apoptosis (mean values) was significantly enhanced in D-HD (18.8 +/- 4.1), HD (19.67 +/- 5.5) and CRF patients (20.8 +/- 4.7) compared to controls (9.6 +/- 3.6; p < 0.05 for CRF vs. controls, HD vs. controls and D-HD vs. controls). No significant differences were observed between D-HD, HD and CRF sera on apoptosis rate, caspase-3 activity and phagocytic capacity of U937 monocytes. This study demonstrates that the plasma of various HD schedules was unable to reduce monocyte apoptosis induced by uremia. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15627741     DOI: 10.1159/000082015

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  2 in total

Review 1.  Monocytes in Uremia.

Authors:  Matthias Girndt; Bogusz Trojanowicz; Christof Ulrich
Journal:  Toxins (Basel)       Date:  2020-05-21       Impact factor: 4.546

2.  Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis.

Authors:  Susana Coimbra; Susana Rocha; Henrique Nascimento; Maria João Valente; Cristina Catarino; Petronila Rocha-Pereira; Maria Sameiro-Faria; José Gerardo Oliveira; José Madureira; João Carlos Fernandes; Vasco Miranda; Luís Belo; Elsa Bronze-da-Rocha; Alice Santos-Silva
Journal:  Clin Kidney J       Date:  2020-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.